mibefradil has been researched along with nimodipine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Brust, PF; Hans, M; Harpold, MM; Prodanovich, P; Stauderman, KA; Urrutia, A; Washburn, MS; Williams, ME | 1 |
| Andrade, R; Hu, HJ; Pan, ZH; Perring, P | 1 |
| Connolly, TM; Figueroa, DJ; Lawlor, AM; Liang, HA; Liu, Y; Salata, JJ; Xia, M | 1 |
| Kahlert, S; Martínez-Sánchez, M; Reiser, G; Reymann, KG; Schröder, UH; Striggow, F | 1 |
| Berggren, PO; Billestrup, N; Kapelioukh, IL; Karlsen, AE; Mandrup-Poulsen, T; Størling, J; Zaitsev, SV | 1 |
| Badawi, JK; Bross, S; Kamp, S; Kwon, ST; Langbein, S; Li, H | 1 |
| Hata, R; Kato, Y; Kubota, E; Miyazaki, K; Ozawa, S; St-Pierre, Y; Tsukuda, M | 1 |
| Fei, H; Wang, Q; Zhao, B; Zhao, S | 1 |
| Du, X; Huang, D; Huang, S; Li, L; Yan, Y; Zhang, H; Zhou, N | 1 |
| Braszko, JJ | 1 |
17 other study(ies) available for mibefradil and nimodipine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
Structure and functional characterization of a novel human low-voltage activated calcium channel.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Animals; Barium; Benzimidazoles; Blotting, Northern; Cadmium; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Channels, T-Type; Cells, Cultured; Cloning, Molecular; Diuretics; DNA, Complementary; Electric Stimulation; Electrophysiology; Humans; Ion Channel Gating; Kidney; Kinetics; Membrane Potentials; Mibefradil; Molecular Sequence Data; Nickel; Nimodipine; Oocytes; Recombinant Proteins; RNA, Messenger; Sequence Homology, Amino Acid; Tetrahydronaphthalenes; Transcription, Genetic; Verapamil; Xenopus | 1999 |
T-type Ca(2+) channels mediate neurotransmitter release in retinal bipolar cells.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels, T-Type; Chelating Agents; Cobalt; Egtazic Acid; Electric Capacitance; Exocytosis; Membrane Potentials; Mibefradil; Neurotransmitter Agents; Nimodipine; Patch-Clamp Techniques; Presynaptic Terminals; Rats; Rats, Long-Evans; Retina; RNA, Messenger; Synaptic Transmission | 2001 |
Functional expression of L- and T-type Ca2+ channels in murine HL-1 cells.
Topics: Animals; Calcium; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Line; Electric Conductivity; Heart Atria; Ion Transport; Mibefradil; Mice; Myocytes, Cardiac; Nimodipine; Patch-Clamp Techniques; Pimozide; Potassium; Verapamil | 2004 |
Na(+) and Ca(2+) homeostasis pathways, cell death and protection after oxygen-glucose-deprivation in organotypic hippocampal slice cultures.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Boron Compounds; Calcium; Calcium Channel Blockers; Cell Death; Clonazepam; Dantrolene; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Fura-2; Glucose; Hippocampus; Hypoxia; In Situ Nick-End Labeling; Indoles; Intracellular Space; Ion Exchange; Lidocaine; Mibefradil; Nimodipine; Organ Culture Techniques; Quinoxalines; Rats; Rats, Wistar; Sodium; Sodium Channel Blockers; Thiazepines; Thiourea; Time Factors | 2004 |
Calcium has a permissive role in interleukin-1beta-induced c-jun N-terminal kinase activation in insulin-secreting cells.
Topics: Animals; Calcium; Calcium Channel Blockers; Cell Line; Drug Synergism; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Insulin; Insulin Secretion; Interleukin-1; Intracellular Membranes; Islets of Langerhans; JNK Mitogen-Activated Protein Kinases; Mibefradil; Mice; NF-kappa B; Nimodipine; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Inbred WF; Signal Transduction | 2005 |
Inhibitory effects of L- and T-type calcium antagonists on contractions of human detrusor muscle.
Topics: Adult; Aged; Analysis of Variance; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Carbachol; Diltiazem; Female; Humans; In Vitro Techniques; Male; Mibefradil; Middle Aged; Muscle Contraction; Muscle, Smooth; Nifedipine; Nimodipine; Potassium; Urinary Bladder; Verapamil | 2006 |
Acidic extracellular pH increases calcium influx-triggered phospholipase D activity along with acidic sphingomyelinase activation to induce matrix metalloproteinase-9 expression in mouse metastatic melanoma.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Line, Tumor; Chelating Agents; Desipramine; Egtazic Acid; Enzyme Activation; Extracellular Fluid; Hydrogen-Ion Concentration; Indolizines; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Melanoma; Mibefradil; Mice; NF-kappa B; Nimodipine; Perhexiline; Phenethylamines; Phospholipase D; Phosphorylation; Promoter Regions, Genetic; Sphingomyelin Phosphodiesterase | 2007 |
Requirements of calcium fluxes and ERK kinase activation for glucose- and interleukin-1beta-induced beta-cell apoptosis.
Topics: Animals; Apoptosis; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Egtazic Acid; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glucose; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Interleukin-1beta; Ion Channel Gating; Ionomycin; Mibefradil; Nimodipine; Rats; Sulfonamides; Thapsigargin | 2008 |
Suppression of KV7/KCNQ potassium channel enhances neuronal differentiation of PC12 cells.
Topics: Animals; Anthracenes; Calcium; Calcium Channels, T-Type; Central Nervous System Agents; Cerebral Cortex; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Mibefradil; Nerve Growth Factor; Neurogenesis; Neurons; Nimodipine; PC12 Cells; Potassium; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2016 |
Indispensable role of the voltage-gated calcium channels in the procognitive effects of angiotensin IV.
Topics: Angiotensin II; Animals; Avoidance Learning; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cognition; Exploratory Behavior; Male; Mental Recall; Mibefradil; Nimodipine; Nootropic Agents; Rats, Wistar; Recognition, Psychology | 2017 |